[Studies on amikacin (BB-K8) in the urological field (author's transl)].
D000208:Acute Disease; D000328:Adult; D000613:Aminobutyrates / Q000494:pharmacology / Q000627:therapeutic use; D001419:Bacteria / Q000302:isolation & purification; D003556:Cystitis / Q000188:drug therapy* / Q000382:microbiology / Q000652:urine; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013307:Streptomycin / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy
D000613:Aminobutyrates; D007612:Kanamycin; D013307:Streptomycin